Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation
Authors:
- Stephanie M. RutledgeSRStephanie M. Rutledge
- Rohit NathaniRNRohit Nathani
- Brooke E. WyattBWBrooke E. Wyatt
- Erin EschbachEEErin Eschbach
- Parth TrivediPTParth Trivedi
- Stanley KerznermanSKStanley Kerznerman
- Lily ChuLCLily Chu
- Thomas D. SchianoTSThomas D. Schiano
- Leona Kim-SchlugerLKLeona Kim-Schluger
- Sander FlormanSFSander Florman
- Gene Y. ImGIGene Y. Im
Open Access
- 19 August 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (9)
Abstract
Background: Severe alcohol-associated hepatitis (AH) that is nonresponsive to corticosteroids is associated with high mortality, particularly with concomitant acute-on-chronic liver failure (ACLF). Most patients will not be candidates for liver transplantation (LT) and their outcomes are largely unknown. Our aim was to determine the outcomes of these declined candidates and to derive practical prediction models for transplant-free survival applicable at the time of the waitlist decision. Methods: We analyzed a database of patients with severe AH who were hospitalized at a LT center from January 2012 to July 2021, using the National Death Index for those lacking follow-up. Clinical variables were analyzed based on the endpoints of mortality at 30, 60, 90, and 180 days. Logistic and Cox regression analyses were used for model derivation. Results: Over 9.5 years, 206 patients with severe AH were declined for LT, mostly for unfavorable psychosocial profiles, with a mean MELD of 33 (±8), and 61% with ACLF. Over a median follow-up of 521 (17.5–1368) days, 58% (119/206) died at a median of 21 (9–124) days. Of 32 variables, only age added prognostic value to MELD and ACLF grade. CLIF-C ACLF score and 2 new models, MELD-Age and ACLF-Age, had similar predictability (AUROC: 0.73, 0.73, 0.72, respectively), outperforming Lille and Maddrey’s (AUROC: 0.63, 0.62). In internal cross-validation, the average AUROC was 0.74. ACLF grade ≥2, MELD score >35, and age >45 years were useful cutoffs for predicting increased 90-day mortality from waitlist decision. Only two patients initially declined for LT for AH subsequently underwent LT (1%). Conclusions: Patients with severe AH declined for LT have high short-term mortality and rare rates of subsequent LT. Age added to MELD or ACLF grade enhances survival prediction at the time of waitlist decision in patients with severe AH declined for LT.Keywords
This publication has 33 references indexed in Scilit:
- Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver FailureHepatology Communications, 2021
- Recovery and outcomes of patients denied early liver transplantation for severe alcohol‐associated hepatitisHepatology, 2021
- Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic HepatitisLiver Transplantation, 2021
- Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver DiseasesHepatology, 2019
- Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long‐term survivalHepatology, 2017
- Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective studyHepatology, 2017
- Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosisHepatology, 2015
- Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitisHepatology, 2015
- Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic HepatitisJAMA, 2013
- The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroidsHepatology, 2007